Who owns Aardvark Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of AARD from SEC Form 13F filings across 71 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 71 institutions disclosed 9.4M shares of Aardvark Therapeutics, Inc. worth $54.3M — about 43.2% of shares outstanding; the largest disclosed holder is Decheng Capital LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
71
13F holders
$54.3M
value, 2026 filers
43.2%
of shares outstanding (9.4M sh)
19
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of AARD's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Decheng Capital LLC | 3.9M | $22.6M | 3.1% | 17.9% | 0.0% |
| 2 | CITADEL ADVISORS LLC | 1.3M | $7.4M | 0.0% | 5.9% | +3.2% |
| 3 | Laurion Capital Management LP | 1.0M | $6.0M | 0.2% | 4.7% | 0.0% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 562,877 | $3.2M | 0.0% | 2.6% | +1.6% |
| 5 | AQR CAPITAL MANAGEMENT LLC | 480,249 | $2.8M | 0.0% | 2.2% | +257.1% |
| 6 | EcoR1 Capital, LLCNEW | 396,194 | $2.3M | 0.1% | 1.8% | new |
| 7 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 300,000 | $1.7M | 0.0% | 1.4% | 0.0% |
| 8 | BlackRock, Inc. | 187,045 | $1.1M | 0.0% | 0.9% | -76.4% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 149,844 | $863,529 | 0.0% | 0.7% | -51.6% |
| 10 | CANTOR FITZGERALD, L. P. | 116,582 | $671,512 | 0.0% | 0.5% | +74.8% |
| 11 | TWO SIGMA INVESTMENTS, LP | 108,377 | $624,252 | 0.0% | 0.5% | -33.7% |
| 12 | RAYMOND JAMES FINANCIAL INC | 79,284 | $456,676 | 0.0% | 0.4% | +628.0% |
| 13 | VANGUARD FIDUCIARY TRUST CO | 75,172 | $432,991 | 0.0% | 0.3% | -9.7% |
| 14 | Woodline Partners LP | 72,429 | $417,191 | 0.0% | 0.3% | 0.0% |
| 15 | MILLENNIUM MANAGEMENT LLC | 69,948 | $402,900 | 0.0% | 0.3% | -28.9% |
| 16 | STATE STREET CORP | 59,273 | $341,412 | 0.0% | 0.3% | -70.3% |
| 17 | J. Goldman & Co LPNEW | 40,500 | $233,280 | 0.0% | 0.2% | new |
| 18 | IEQ CAPITAL, LLC | 38,382 | $221,080 | 0.0% | 0.2% | +132.8% |
| 19 | UBS Group AG | 35,639 | $205,281 | 0.0% | 0.2% | -77.4% |
| 20 | MORGAN STANLEY | 30,177 | $173,820 | 0.0% | 0.1% | +71.8% |
| 21 | NORTHERN TRUST CORP | 28,080 | $161,741 | 0.0% | 0.1% | -68.3% |
| 22 | CITIGROUP INC | 26,299 | $151,482 | 0.0% | 0.1% | -43.2% |
| 23 | Cresset Asset Management, LLC | 24,033 | $138,430 | 0.0% | 0.1% | -44.4% |
| 24 | SUSQUEHANNA INTERNATIONAL GROUP, LLPNEW | 24,025 | $138,384 | 0.0% | 0.1% | new |
| 25 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 24,000 | $138,240 | 0.0% | 0.1% | -11.1% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.